Literature DB >> 29574717

Dynamic SAP102 expression in the hippocampal subregions of rats and APP/PS1 mice of various ages.

Dongning Su1, Hui Liu2, Tianrong Liu3, Xin Zhang4, Wei Yang5, Yizhi Song6, Jinping Liu7, Yan Wu6, Lirong Chang6.   

Abstract

The hippocampus is a structurally and functionally complex brain area that plays important and diverse roles in higher brain functions, such as learning and memory, and mounting evidence indicates that different hippocampal subregions play distinctive roles. The hippocampus is also one of the first regions in the brain to suffer damage in Alzheimer's disease (AD). Synaptic dysfunction in the hippocampus, rather than neuronal loss per se, is paralleled by behavioural and functional deficits in AD. The membrane-associated guanylate kinase (MAGUK) family of proteins, including SAP102, PSD-95, PSD-93 and SAP97, have long been recognized as essential components of the postsynaptic density (PSD) at excitatory synapses. Hippocampal spines are the predominant synaptic transmission sites of excitatory glutamatergic synapses. During postnatal brain development, individual MAGUK members show distinct expression patterns. Although SAP102 has been confirmed as the dominant scaffold protein in neonatal synapses, its expression profiles in adult and ageing rodent hippocampi are discrepant. Furthermore, in AD brains, significantly reduced SAP102 protein levels have been found, suggesting that SAP102 may be related to AD progression; however, the precise mechanism underlying this result remains unclear. Herein, we observed distinct SAP102 expression profiles in the hippocampal CA1, CA3 and DG subregions of rats and APPswe/PS1dE9 (APP/PS1) mice at various ages using immunofluorescence. In Wistar rats, SAP102 was not only highly expressed in the hippocampal subregions of neonatal rats but also maintained relatively high expression levels in adult hippocampi and displayed no obvious decreases in the CA1 and DG subregions of aged rats. Surprisingly, we observed abnormally high SAP102 expression levels in the CA1 stratum moleculare and CA3 stratum polymorphum subregions of 2-month-old APP/PS1 mice, but low SAP102 levels in the DG and CA3 subregions of 7-month-old APP/PS1 mice, reflecting the subregion-specific reactivity and vulnerability of AD mouse models in different disease stages. Our findings provide fundamental data to support the functional differences of SAP102 in different hippocampal subregions during postnatal periods and may serve as the basis for additional functional studies on SAP102 in normal physiological conditions and different stages of AD.
© 2018 Anatomical Society.

Entities:  

Keywords:  APP/PS1; Alzheimer's disease; SAP102; hippocampus

Mesh:

Substances:

Year:  2018        PMID: 29574717      PMCID: PMC5979819          DOI: 10.1111/joa.12807

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  64 in total

Review 1.  Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines.

Authors:  K E Sorra; K M Harris
Journal:  Hippocampus       Date:  2000       Impact factor: 3.899

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development.

Authors:  G M Elias; L A B Elias; P F Apostolides; A R Kriegstein; R A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

4.  Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model.

Authors:  Cui Lv; Lei Wang; Xiaoli Liu; Shijun Yan; Shirley ShiDu Yan; Yongyan Wang; Wensheng Zhang
Journal:  Neuropharmacology       Date:  2014-09-28       Impact factor: 5.250

5.  Differential expression of PSD proteins in age-related spatial learning impairments.

Authors:  Myriel Nyffeler; Wei-Ning Zhang; Joram Feldon; Irene Knuesel
Journal:  Neurobiol Aging       Date:  2005-12-28       Impact factor: 4.673

6.  Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology.

Authors:  Dustin T Proctor; Elizabeth J Coulson; Peter R Dodd
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Impairment of synaptic development in the hippocampus of diabetic Goto-Kakizaki rats.

Authors:  Yuki Matsunaga; Takayuki Negishi; Akinori Hatakeyama; Yuta Kawagoe; Erika Sawano; Tomoko Tashiro
Journal:  Int J Dev Neurosci       Date:  2016-07-18       Impact factor: 2.457

8.  Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.

Authors:  Shuang-Qing Chen; Pei-Jun Wang; Gao-Jun Ten; Wei Zhan; Ming-Hua Li; Feng-Chao Zang
Journal:  Dement Geriatr Cogn Disord       Date:  2010-01-06       Impact factor: 2.959

9.  Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer's disease.

Authors:  Patricia Kelly; Paul Denver; Simon C Satchell; Maximilian Ackermann; Moritz A Konerding; Christopher A Mitchell
Journal:  Angiogenesis       Date:  2017-07-25       Impact factor: 9.596

10.  Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer's disease.

Authors:  Marlene J Végh; Céline M Heldring; Willem Kamphuis; Sara Hijazi; Arie J Timmerman; Ka Wan Li; Pim van Nierop; Huibert D Mansvelder; Elly M Hol; August B Smit; Ronald E van Kesteren
Journal:  Acta Neuropathol Commun       Date:  2014-06-29       Impact factor: 7.801

View more
  1 in total

1.  Schizophrenia-associated SAP97 mutations increase glutamatergic synapse strength in the dentate gyrus and impair contextual episodic memory in rats.

Authors:  Yuni Kay; Linda Tsan; Elizabeth A Davis; Chen Tian; Léa Décarie-Spain; Anastasiia Sadybekov; Anna N Pushkin; Vsevolod Katritch; Scott E Kanoski; Bruce E Herring
Journal:  Nat Commun       Date:  2022-02-10       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.